The store will not work correctly when cookies are disabled.
N4-(2,3-dimethylphenyl)-N6-methylpyrimidine-2,4,6-triamine
ID: ALA4578510
PubChem CID: 80761829
Max Phase: Preclinical
Molecular Formula: C13H17N5
Molecular Weight: 243.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNc1cc(Nc2cccc(C)c2C)nc(N)n1
Standard InChI: InChI=1S/C13H17N5/c1-8-5-4-6-10(9(8)2)16-12-7-11(15-3)17-13(14)18-12/h4-7H,1-3H3,(H4,14,15,16,17,18)
Standard InChI Key: JDEFXJIIKYRHNP-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
11.2453 -27.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2441 -27.8487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9522 -28.2577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6618 -27.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6590 -27.0256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9504 -26.6203 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3652 -26.6143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0744 -27.0203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5375 -26.6208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9520 -29.0749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2442 -29.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5400 -29.0715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8327 -29.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8320 -30.2973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5446 -30.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2490 -30.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9587 -30.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5473 -31.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
1 9 1 0
3 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
16 17 1 0
15 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 243.31 | Molecular Weight (Monoisotopic): 243.1484 | AlogP: 2.46 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.86 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.42 | CX LogP: 3.03 | CX LogD: 2.99 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.77 | Np Likeness Score: -1.22 |
References
1. Farand J, Kropf JE, Blomgren P, Xu J, Schmitt AC, Newby ZE, Wang T, Murakami E, Barauskas O, Sudhamsu J, Feng JY, Niedziela-Majka A, Schultz BE, Schwartz K, Viatchenko-Karpinski S, Kornyeyev D, Kashishian A, Fan P, Chen X, Lansdon EB, Ports MO, Currie KS, Watkins WJ, Notte GT.. (2020) Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation., 11 (3): [PMID:32184970] [10.1021/acsmedchemlett.9b00420] |